According to filings with the U.S. Securities and Exchange Commission, Koios Medical is raising up to $500,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Chad McClennan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Koios Medical
Koios DS for Breast is a Smart Ultrasound solution for radiologists diagnosing cancer. Using AI algorithms trained on tens of thousands of images combined with data from pathology results, Koios DS is clinical decision support for a new era of diagnostic excellence. Smart Ultrasound redefines what radiology professionals can discern in the radiology suite. Our proprietary technology and patented methods provide an invaluable second opinion that is already being adopted by leading healthcare institutions to improve diagnostic accuracy, speed clinical decision making, and elevate the quality of care. Our software is FDA cleared for use in the USA.

To learn more about Koios Medical, visit http://koiosmedical.com/

Contact:
Chad McClennan, Chief Executive Officer
732-529-5755
https://www.linkedin.com/in/chadmcclennan/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.